South Sudan vs Saint Kitts and Nevis: The number of people with susceptibility test result for rifampicin
South Sudan
0
in 2021
Saint Kitts and Nevis
0
in 2021
South Sudan rank
146th
Saint Kitts and Nevis rank
146th
The number of people with susceptibility test result for rifampicin over time
- South Sudan
- Saint Kitts and Nevis
How they compare
South Sudan currently reports 0 against 0 in Saint Kitts and Nevis, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was South Sudan ahead.
South Sudan ranks 146th and Saint Kitts and Nevis ranks 146th of 155 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.67 | 1 | 76.67 | South Sudan |
| 2020s | 164.5 | 0.5 | 164 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, South Sudan or Saint Kitts and Nevis?
- South Sudan, at 0 against 0 in Saint Kitts and Nevis as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between South Sudan and Saint Kitts and Nevis?
- 0, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Saint Kitts and Nevis?
- 5 years are reported by both, from 2017 to 2021.
- How do South Sudan and Saint Kitts and Nevis rank globally for the number of people with susceptibility test result for rifampicin?
- South Sudan ranks 146th and Saint Kitts and Nevis ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.